aluates Reports

$ 0.0

Automative

Global Anti-Peptic Ulcer Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Published Date: May 2025

Report Code: QYRE-Auto-3301

China Anti Peptic Ulcer Drugs Market Report Forecast 2021 2027

BUY CHAPTERS

Global Anti-Peptic Ulcer Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-3301

Report

May 2025

Pages:126

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Astrazeneca plc

Ask-pharm

Takeda

Yangtze River Pharm

Shandong Luoxin

Huadong Medicine

Changzhou Siyao

Beijing Yuekang

Guangdong Dahua

Xian Janssen

Anti-Peptic Ulcer Drugs Market Size

In 2024, the global market size of Anti-Peptic Ulcer Drugs was estimated to be worth US$ 11180 million and is forecast to reach approximately US$ 26650 million by 2031 with a CAGR of 13.4% during the forecast period 2025-2031.

Anti-Peptic Ulcer Drugs Market

Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.

Global Anti-Peptic Ulcer Drugs key players include AstraZeneca, Ask-pharm, Takeda, Yangtze River Pharm, Shandong Luoxin, etc. Global top five players hold a share about 50%.

In terms of product, the segment includes Proton Pump Inhibitors (PPIs), Potassium-Competitive Acid Blockers (P-CAB), Antacids, H2 Antagonists, Ulcer Protective Drugs. And in terms of application, the application includes Gastritis, Gastric Ulcers, Duodenal Ulcers, Gastroesophageal Reflux Disease (GERD).

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-Peptic Ulcer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Peptic Ulcer Drugs.

The Anti-Peptic Ulcer Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-Peptic Ulcer Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Anti-Peptic Ulcer Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Market Segmentation

Scope of Anti-Peptic Ulcer Drugs Market Report

Report Metric	Details
Report Name	Anti-Peptic Ulcer Drugs Market
Forecasted market size in 2031	approximately US$ 26650 million
CAGR	13.4%
Forecasted years	2025 - 2031
Segment by Type	Proton Pump Inhibitors (PPIs) Potassium-Competitive Acid Blockers (P-CAB) Antacids H2 Antagonists Ulcer Protective Drugs
Segment by Application	Gastritis Gastric Ulcers Duodenal Ulcers Gastroesophageal Reflux Disease (GERD)
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca, Ask-pharm, Takeda, Yangtze River Pharm, Shandong Luoxin, Huadong Medicine, Changzhou Siyao, Beijing Yuekang, Guangdong Dahua, Xian Janssen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Anti-Peptic Ulcer Drugs in global and regional level.
Chapter 3: Detailed analysis of Anti-Peptic Ulcer Drugs company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-Peptic Ulcer Drugs revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Anti-Peptic Ulcer Drugs Market size in 2031?

Ans: The Anti-Peptic Ulcer Drugs Market size in 2031 will be approximately US$ 26650 million.

What is the market share of major companies in Anti-Peptic Ulcer Drugs Market?

Ans: Global top five players hold a share about 50%.

Who are the main players in the Anti-Peptic Ulcer Drugs Market report?

Ans: The main players in the Anti-Peptic Ulcer Drugs Market are AstraZeneca, Ask-pharm, Takeda, Yangtze River Pharm, Shandong Luoxin, Huadong Medicine, Changzhou Siyao, Beijing Yuekang, Guangdong Dahua, Xian Janssen

What are the Application segmentation covered in the Anti-Peptic Ulcer Drugs Market report?

Ans: The Applications covered in the Anti-Peptic Ulcer Drugs Market report are Gastritis, Gastric Ulcers, Duodenal Ulcers, Gastroesophageal Reflux Disease (GERD)

What are the Type segmentation covered in the Anti-Peptic Ulcer Drugs Market report?

Ans: The Types covered in the Anti-Peptic Ulcer Drugs Market report are Proton Pump Inhibitors (PPIs), Potassium-Competitive Acid Blockers (P-CAB), Antacids, H2 Antagonists, Ulcer Protective Drugs

Recommended Reports

Ulcer and GI Drugs

Gastroesophageal Disease

IBD and Colitis

Market trends :

Topic	Trends
Global	the anti-peptic ulcer drugs market is experiencing rapid growth driven by rising prevalence of gastrointestinal disorders and increased adoption of advanced drug classes globally.
Type	Proton Pump Inhibitors (PPIs) - proton pump inhibitors remain the dominant drug class due to their proven efficacy in treating acid-related gastrointestinal conditions. Potassium-Competitive Acid Blockers (P-CAB) - potassium-competitive acid blockers are gaining traction as next-generation therapies for acid suppression, offering rapid and sustained effects. Antacids - antacids maintain steady demand as over-the-counter options for immediate symptom relief in mild gastrointestinal discomfort. H2 Antagonists - h2 antagonists face declining usage due to the superior efficacy and longer duration of action of newer drug classes. Ulcer Protective Drugs - ulcer protective drugs are increasingly used as adjunct therapies to enhance mucosal defense in peptic ulcer management.
Application	Gastritis - rising incidence of gastritis is fueling demand for targeted anti-peptic ulcer therapies across all major regions. Gastric Ulcers - increased diagnosis and awareness of gastric ulcers are driving the adoption of advanced anti-ulcer medications. Duodenal Ulcers - duodenal ulcer treatment is benefiting from improved drug formulations and patient compliance initiatives. Gastroesophageal Reflux Disease (GERD) - growing prevalence of gerd is a key factor boosting the market for anti-peptic ulcer drugs, especially in urban populations.
Region	North America - north america leads in adoption of innovative anti-peptic ulcer drugs due to advanced healthcare infrastructure and high disease awareness. EMEA - emea region shows steady market expansion driven by rising healthcare expenditure and increasing prevalence of gastrointestinal disorders. APAC - apac is witnessing the fastest market growth fueled by large patient populations and improving access to healthcare. LATAM - latam market growth is supported by increasing investments in healthcare and rising incidence of peptic ulcer diseases.

1 Study Coverage

1.1 Anti-Peptic Ulcer Drugs Product Introduction

1.2 Market by Type

1.2.1 Global Anti-Peptic Ulcer Drugs Market Size Growth Rate by Type (2020 VS 2024 VS 2031)

1.2.2 Proton Pump Inhibitors (PPIs)

1.2.3 Potassium-Competitive Acid Blockers (P-CAB)

1.2.4 Antacids

1.2.5 H2 Antagonists

1.2.6 Ulcer Protective Drugs

1.3 Market by Application

1.3.1 Global Anti-Peptic Ulcer Drugs Market Size Growth Rate by Application (2020 VS 2024 VS 2031)

1.3.2 Gastritis

1.3.3 Gastric Ulcers

1.3.4 Duodenal Ulcers

1.3.5 Gastroesophageal Reflux Disease (GERD)

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Anti-Peptic Ulcer Drugs Market Size Estimates and Forecasts

2.2 Anti-Peptic Ulcer Drugs Market Size by Region: 2024 Versus 2031

2.2.1 Global Anti-Peptic Ulcer Drugs Revenue by Region: 2020-2025

2.2.2 Global Anti-Peptic Ulcer Drugs Revenue Forecast by Region (2026-2031)

2.2.3 Global Anti-Peptic Ulcer Drugs Revenue Market Share by Region (2020-2031)

3 Market Segments

3.1 Breakdown Data by Type

3.1.1 Global Anti-Peptic Ulcer Drugs Revenue by Type (2020-2031)

3.1.2 Global Anti-Peptic Ulcer Drugs Revenue Market Share by Type (2020-2031)

3.2 Breakdown Data by Application

3.2.1 Global Anti-Peptic Ulcer Drugs Revenue by Application (2020-2031)

3.2.2 Global Anti-Peptic Ulcer Drugs Revenue Market Share by Application (2020-2031)

3.3 by Type and by Application Crossing Analysis

3.3.1 Proton Pump Inhibitors (PPIs) of Anti-Peptic Ulcer Drugs Revenue Market Share by Application

3.3.2 Potassium-Competitive Acid Blockers (P-CAB) of Anti-Peptic Ulcer Drugs Revenue Market Share by Application

3.3.3 Antacids of Anti-Peptic Ulcer Drugs Revenue Market Share by Application

3.3.4 H2 Antagonists of Anti-Peptic Ulcer Drugs Revenue Market Share by Application

3.3.5 Ulcer Protective Drugs of Anti-Peptic Ulcer Drugs Revenue Market Share by Application

4 Global Anti-Peptic Ulcer Drugs by Company

4.1 Global Anti-Peptic Ulcer Drugs Revenue by Company (2020-2025)

4.2 Global Anti-Peptic Ulcer Drugs Revenue Share by Company (2020-2025)

4.3 Competitive Landscape

4.3.1 Key Anti-Peptic Ulcer Drugs Companies around the World: Ranking by Revenue

4.3.2 Global Anti-Peptic Ulcer Drugs Market Concentration Ratio (CR5 and HHI) & (2020-2025)

4.3.3 Global Anti-Peptic Ulcer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.4 Global Anti-Peptic Ulcer Drugs Companies Headquarters & Product Type

4.4.1 Global Anti-Peptic Ulcer Drugs Companies Headquarters

4.4.2 Date of International Companies Enter into Anti-Peptic Ulcer Drugs Market

4.4.3 Global Anti-Peptic Ulcer Drugs Companies Product & Service

4.4.4 Proton Pump Inhibitors (PPIs) Revenue Market Share of Anti-Peptic Ulcer Drugs by Company

4.4.5 Potassium-Competitive Acid Blockers (P-CAB) Revenue Market Share of Anti-Peptic Ulcer Drugs by Company

4.4.6 Antacids Revenue Market Share of Anti-Peptic Ulcer Drugs by Company

4.4.7 H2 Antagonists Revenue Market Share of Anti-Peptic Ulcer Drugs by Company

4.4.8 Ulcer Protective Drugs Revenue Market Share of Anti-Peptic Ulcer Drugs by Company

4.5 Global Anti-Peptic Ulcer Drugs Mergers & Acquisitions, Expansion Plans

5 Company Profiles

5.1 AstraZeneca

5.1.1 AstraZeneca Corporation Information

5.1.2 AstraZeneca Description, Business Overview

5.1.3 AstraZeneca Anti-Peptic Ulcer Drugs Products Offered

5.1.4 AstraZeneca Anti-Peptic Ulcer Drugs Revenue and Gross Margin (2020-2025)

5.1.5 AstraZeneca Anti-Peptic Ulcer Drugs Revenue by Product in 2024

5.1.6 AstraZeneca Anti-Peptic Ulcer Drugs Revenue by Application in 2024

5.1.7 AstraZeneca Anti-Peptic Ulcer Drugs Revenue by Geographic Area in 2024

5.1.8 AstraZeneca Recent Developments

5.2 Ask-pharm

5.2.1 Ask-pharm Corporation Information

5.2.2 Ask-pharm Description, Business Overview

5.2.3 Ask-pharm Anti-Peptic Ulcer Drugs Products Offered

5.2.4 Ask-pharm Anti-Peptic Ulcer Drugs Revenue and Gross Margin (2020-2025)

5.2.5 Ask-pharm Anti-Peptic Ulcer Drugs Revenue by Product in 2024

5.2.6 Ask-pharm Anti-Peptic Ulcer Drugs Revenue by Application in 2024

5.2.7 Ask-pharm Anti-Peptic Ulcer Drugs Revenue by Geographic Area in 2024

5.2.8 Ask-pharm Recent Developments

5.3 Takeda

5.3.1 Takeda Corporation Information

5.3.2 Takeda Description, Business Overview

5.3.3 Takeda Anti-Peptic Ulcer Drugs Products Offered

5.3.4 Takeda Anti-Peptic Ulcer Drugs Revenue and Gross Margin (2020-2025)

5.3.5 Takeda Anti-Peptic Ulcer Drugs Revenue by Product in 2024

5.3.6 Takeda Anti-Peptic Ulcer Drugs Revenue by Application in 2024

5.3.7 Takeda Anti-Peptic Ulcer Drugs Revenue by Geographic Area in 2024

5.3.8 Takeda Recent Developments

5.4 Yangtze River Pharm

5.4.1 Yangtze River Pharm Corporation Information

5.4.2 Yangtze River Pharm Description, Business Overview

5.4.3 Yangtze River Pharm Anti-Peptic Ulcer Drugs Products Offered

5.4.4 Yangtze River Pharm Anti-Peptic Ulcer Drugs Revenue and Gross Margin (2020-2025)

5.4.5 Yangtze River Pharm Anti-Peptic Ulcer Drugs Revenue by Product in 2024

5.4.6 Yangtze River Pharm Anti-Peptic Ulcer Drugs Revenue by Application in 2024

5.4.7 Yangtze River Pharm Anti-Peptic Ulcer Drugs Revenue by Geographic Area in 2024

5.4.8 Yangtze River Pharm Recent Developments

5.5 Shandong Luoxin

5.5.1 Shandong Luoxin Corporation Information

5.5.2 Shandong Luoxin Description, Business Overview

5.5.3 Shandong Luoxin Anti-Peptic Ulcer Drugs Products Offered

5.5.4 Shandong Luoxin Anti-Peptic Ulcer Drugs Revenue and Gross Margin (2020-2025)

5.5.5 Shandong Luoxin Anti-Peptic Ulcer Drugs Revenue by Product in 2024

5.5.6 Shandong Luoxin Anti-Peptic Ulcer Drugs Revenue by Application in 2024

5.5.7 Shandong Luoxin Anti-Peptic Ulcer Drugs Revenue by Geographic Area in 2024

5.5.8 Shandong Luoxin Recent Developments

5.6 Huadong Medicine

5.6.1 Huadong Medicine Corporation Information

5.6.2 Huadong Medicine Description, Business Overview

5.6.3 Huadong Medicine Anti-Peptic Ulcer Drugs Products Offered

5.6.4 Huadong Medicine Anti-Peptic Ulcer Drugs Revenue and Gross Margin (2020-2025)

5.6.5 Huadong Medicine Anti-Peptic Ulcer Drugs Revenue by Product in 2024

5.6.6 Huadong Medicine Anti-Peptic Ulcer Drugs Revenue by Application in 2024

5.6.7 Huadong Medicine Anti-Peptic Ulcer Drugs Revenue by Geographic Area in 2024

5.6.8 Huadong Medicine Recent Developments

5.7 Changzhou Siyao

5.7.1 Changzhou Siyao Corporation Information

5.7.2 Changzhou Siyao Description, Business Overview

5.7.3 Changzhou Siyao Anti-Peptic Ulcer Drugs Products Offered

5.7.4 Changzhou Siyao Anti-Peptic Ulcer Drugs Revenue and Gross Margin (2020-2025)

5.7.5 Changzhou Siyao Anti-Peptic Ulcer Drugs Revenue by Product in 2024

5.7.6 Changzhou Siyao Anti-Peptic Ulcer Drugs Revenue by Application in 2024

5.7.7 Changzhou Siyao Anti-Peptic Ulcer Drugs Revenue by Geographic Area in 2024

5.7.8 Changzhou Siyao Recent Developments

5.8 Beijing Yuekang

5.8.1 Beijing Yuekang Corporation Information

5.8.2 Beijing Yuekang Description, Business Overview

5.8.3 Beijing Yuekang Anti-Peptic Ulcer Drugs Products Offered

5.8.4 Beijing Yuekang Anti-Peptic Ulcer Drugs Revenue and Gross Margin (2020-2025)

5.8.5 Beijing Yuekang Anti-Peptic Ulcer Drugs Revenue by Product in 2024

5.8.6 Beijing Yuekang Anti-Peptic Ulcer Drugs Revenue by Application in 2024

5.8.7 Beijing Yuekang Anti-Peptic Ulcer Drugs Revenue by Geographic Area in 2024

5.8.8 Beijing Yuekang Recent Developments

5.9 Guangdong Dahua

5.9.1 Guangdong Dahua Corporation Information

5.9.2 Guangdong Dahua Description, Business Overview

5.9.3 Guangdong Dahua Anti-Peptic Ulcer Drugs Products Offered

5.9.4 Guangdong Dahua Anti-Peptic Ulcer Drugs Revenue and Gross Margin (2020-2025)

5.9.5 Guangdong Dahua Anti-Peptic Ulcer Drugs Revenue by Product in 2024

5.9.6 Guangdong Dahua Anti-Peptic Ulcer Drugs Revenue by Application in 2024

5.9.7 Guangdong Dahua Anti-Peptic Ulcer Drugs Revenue by Geographic Area in 2024

5.9.8 Guangdong Dahua Recent Developments

5.10 Xian Janssen

5.10.1 Xian Janssen Corporation Information

5.10.2 Xian Janssen Description, Business Overview

5.10.3 Xian Janssen Anti-Peptic Ulcer Drugs Products Offered

5.10.4 Xian Janssen Anti-Peptic Ulcer Drugs Revenue and Gross Margin (2020-2025)

5.10.5 Xian Janssen Anti-Peptic Ulcer Drugs Revenue by Product in 2024

5.10.6 Xian Janssen Anti-Peptic Ulcer Drugs Revenue by Application in 2024

5.10.7 Xian Janssen Anti-Peptic Ulcer Drugs Revenue by Geographic Area in 2024

5.10.8 Xian Janssen Recent Developments

6 North America

6.1 North America Anti-Peptic Ulcer Drugs Market Size YoY Growth 2020-2031

6.2 North America Anti-Peptic Ulcer Drugs Market Facts & Figures by Country (2020-2031)

6.3 North America Anti-Peptic Ulcer Drugs Revenue by Type (2020-2025)

6.4 North America Anti-Peptic Ulcer Drugs Revenue by Application (2020-2025)

7 Asia-Pacific

7.1 Asia-Pacific Anti-Peptic Ulcer Drugs Market Size YoY Growth 2020-2031

7.2 Asia-Pacific Anti-Peptic Ulcer Drugs Market Facts & Figures by Region (2020-2031)

7.3 Asia-Pacific Anti-Peptic Ulcer Drugs Revenue by Type (2020-2025)

7.4 Asia-Pacific Anti-Peptic Ulcer Drugs Revenue by Application (2020-2025)

8 Europe

8.1 Europe Anti-Peptic Ulcer Drugs Market Size YoY Growth 2020-2031

8.2 Europe Anti-Peptic Ulcer Drugs Market Facts & Figures by Country (2020-2031)

8.3 Europe Anti-Peptic Ulcer Drugs Revenue by Type (2020-2025)

8.4 Europe Anti-Peptic Ulcer Drugs Revenue by Application (2020-2025)

9 Latin America

9.1 Latin America Anti-Peptic Ulcer Drugs Market Size YoY Growth 2020-2031

9.2 Latin America Anti-Peptic Ulcer Drugs Market Facts & Figures by Country (2020-2031)

9.3 Latin America Anti-Peptic Ulcer Drugs Revenue by Type (2020-2025)

9.4 Latin America Anti-Peptic Ulcer Drugs Revenue by Application (2020-2025)

10 Middle East and Africa

10.1 Latin America Anti-Peptic Ulcer Drugs Market Size YoY Growth 2020-2031

10.2 Middle East and Africa Anti-Peptic Ulcer Drugs Market Facts & Figures by Country (2020-2031)

10.3 Middle East and Africa Anti-Peptic Ulcer Drugs Revenue by Type (2020-2025)

10.4 Middle East and Africa Anti-Peptic Ulcer Drugs Revenue by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

11.1 Anti-Peptic Ulcer Drugs Supply Chain Analysis

11.2 Anti-Peptic Ulcer Drugs Key Raw Materials and Upstream Suppliers

11.3 Anti-Peptic Ulcer Drugs Clients Analysis

11.4 Anti-Peptic Ulcer Drugs Sales Channel and Sales Model Analysis

11.4.1 Anti-Peptic Ulcer Drugs Distribution Channel Analysis: Indirect Sales VS Direct Sales

11.4.2 Anti-Peptic Ulcer Drugs Distribution Channel Analysis: Online Sales VS Offline Sales

11.4.3 Anti-Peptic Ulcer Drugs Distributors

12 Anti-Peptic Ulcer Drugs Market Dynamics

12.1 Anti-Peptic Ulcer Drugs Industry Trends

12.2 Anti-Peptic Ulcer Drugs Market Drivers

12.3 Anti-Peptic Ulcer Drugs Market Challenges

12.4 Anti-Peptic Ulcer Drugs Market Restraints

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.1.1 Research Programs/Design

14.1.1.2 Market Size Estimation

14.1.1.3 Market Breakdown and Data Triangulation

14.1.2 Data Source

14.1.2.1 Secondary Sources

14.1.2.2 Primary Sources

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

Astrazeneca plc

Ask-pharm

Takeda

Yangtze River Pharm

Shandong Luoxin

Huadong Medicine

Changzhou Siyao

Beijing Yuekang

Guangdong Dahua

Xian Janssen

List of Tables

Table 1. Global Anti-Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Anti-Peptic Ulcer Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Anti-Peptic Ulcer Drugs Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Anti-Peptic Ulcer Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Anti-Peptic Ulcer Drugs Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 6. Global Anti-Peptic Ulcer Drugs Revenue by Type (2020-2025) & (US$ Million)

Table 7. Global Anti-Peptic Ulcer Drugs Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 8. Global Anti-Peptic Ulcer Drugs Revenue by Application (2020-2025) & (US$ Million)

Table 9. Global Anti-Peptic Ulcer Drugs Revenue Forecast by Application (2026-2031) & (US$ Million)

Table 10. Anti-Peptic Ulcer Drugs Revenue by Company (2020-2025) & (US$ Million)

Table 11. Anti-Peptic Ulcer Drugs Revenue Share by Company (2020-2025)

Table 12. Ranking of Global Top Anti-Peptic Ulcer Drugs Players by Revenue (US$ Million) in 2024

Table 13. Global Anti-Peptic Ulcer Drugs Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 14. Global Anti-Peptic Ulcer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Peptic Ulcer Drugs as of 2024)

Table 15. Global Anti-Peptic Ulcer Drugs Companies Headquarters

Table 16. Date of International Companies Enter into Anti-Peptic Ulcer Drugs Market

Table 17. Global Anti-Peptic Ulcer Drugs Companies Product & Service

Table 18. Global Anti-Peptic Ulcer Drugs Mergers & Acquisitions, Expansion Plans

Table 19. AstraZeneca Corporation Information

Table 20. AstraZeneca Description and Business Overview

Table 21. AstraZeneca Anti-Peptic Ulcer Drugs Product

Table 22. AstraZeneca Anti-Peptic Ulcer Drugs Revenue (US$ Million) and Gross Margin (2020-2025)

Table 23. AstraZeneca Revenue Proportion of Anti-Peptic Ulcer Drugs by Product in 2024

Table 24. AstraZeneca Revenue Proportion of Anti-Peptic Ulcer Drugs by Application in 2024

Table 25. AstraZeneca Revenue Proportion of Anti-Peptic Ulcer Drugs by Geographic Area in 2024

Table 26. AstraZeneca Recent Developments

Table 27. Ask-pharm Corporation Information

Table 28. Ask-pharm Description and Business Overview

Table 29. Ask-pharm Anti-Peptic Ulcer Drugs Product

Table 30. Ask-pharm Anti-Peptic Ulcer Drugs Revenue (US$ Million) and Gross Margin (2020-2025)

Table 31. Ask-pharm Revenue Proportion of Anti-Peptic Ulcer Drugs by Product in 2024

Table 32. Ask-pharm Revenue Proportion of Anti-Peptic Ulcer Drugs by Application in 2024

Table 33. Ask-pharm Revenue Proportion of Anti-Peptic Ulcer Drugs by Geographic Area in 2024

Table 34. Ask-pharm Recent Developments

Table 35. Takeda Corporation Information

Table 36. Takeda Description and Business Overview

Table 37. Takeda Anti-Peptic Ulcer Drugs Product

Table 38. Takeda Anti-Peptic Ulcer Drugs Revenue (US$ Million) and Gross Margin (2020-2025)

Table 39. Takeda Revenue Proportion of Anti-Peptic Ulcer Drugs by Product in 2024

Table 40. Takeda Revenue Proportion of Anti-Peptic Ulcer Drugs by Application in 2024

Table 41. Takeda Revenue Proportion of Anti-Peptic Ulcer Drugs by Geographic Area in 2024

Table 42. Takeda Recent Developments

Table 43. Yangtze River Pharm Corporation Information

Table 44. Yangtze River Pharm Description and Business Overview

Table 45. Yangtze River Pharm Anti-Peptic Ulcer Drugs Product

Table 46. Yangtze River Pharm Anti-Peptic Ulcer Drugs Revenue (US$ Million) and Gross Margin (2020-2025)

Table 47. Yangtze River Pharm Revenue Proportion of Anti-Peptic Ulcer Drugs by Product in 2024

Table 48. Yangtze River Pharm Revenue Proportion of Anti-Peptic Ulcer Drugs by Application in 2024

Table 49. Yangtze River Pharm Revenue Proportion of Anti-Peptic Ulcer Drugs by Geographic Area in 2024

Table 50. Yangtze River Pharm Recent Developments

Table 51. Shandong Luoxin Corporation Information

Table 52. Shandong Luoxin Description and Business Overview

Table 53. Shandong Luoxin Anti-Peptic Ulcer Drugs Product

Table 54. Shandong Luoxin Anti-Peptic Ulcer Drugs Revenue (US$ Million) and Gross Margin (2020-2025)

Table 55. Shandong Luoxin Revenue Proportion of Anti-Peptic Ulcer Drugs by Product in 2024

Table 56. Shandong Luoxin Revenue Proportion of Anti-Peptic Ulcer Drugs by Application in 2024

Table 57. Shandong Luoxin Revenue Proportion of Anti-Peptic Ulcer Drugs by Geographic Area in 2024

Table 58. Shandong Luoxin Recent Developments

Table 59. Huadong Medicine Corporation Information

Table 60. Huadong Medicine Description and Business Overview

Table 61. Huadong Medicine Anti-Peptic Ulcer Drugs Product

Table 62. Huadong Medicine Anti-Peptic Ulcer Drugs Revenue (US$ Million) and Gross Margin (2020-2025)

Table 63. Huadong Medicine Revenue Proportion of Anti-Peptic Ulcer Drugs by Product in 2024

Table 64. Huadong Medicine Revenue Proportion of Anti-Peptic Ulcer Drugs by Application in 2024

Table 65. Huadong Medicine Revenue Proportion of Anti-Peptic Ulcer Drugs by Geographic Area in 2024

Table 66. Huadong Medicine Recent Developments

Table 67. Changzhou Siyao Corporation Information

Table 68. Changzhou Siyao Description and Business Overview

Table 69. Changzhou Siyao Anti-Peptic Ulcer Drugs Product

Table 70. Changzhou Siyao Anti-Peptic Ulcer Drugs Revenue (US$ Million) and Gross Margin (2020-2025)

Table 71. Changzhou Siyao Revenue Proportion of Anti-Peptic Ulcer Drugs by Product in 2024

Table 72. Changzhou Siyao Revenue Proportion of Anti-Peptic Ulcer Drugs by Application in 2024

Table 73. Changzhou Siyao Revenue Proportion of Anti-Peptic Ulcer Drugs by Geographic Area in 2024

Table 74. Changzhou Siyao Recent Developments

Table 75. Beijing Yuekang Corporation Information

Table 76. Beijing Yuekang Description and Business Overview

Table 77. Beijing Yuekang Anti-Peptic Ulcer Drugs Product

Table 78. Beijing Yuekang Anti-Peptic Ulcer Drugs Revenue (US$ Million) and Gross Margin (2020-2025)

Table 79. Beijing Yuekang Revenue Proportion of Anti-Peptic Ulcer Drugs by Product in 2024

Table 80. Beijing Yuekang Revenue Proportion of Anti-Peptic Ulcer Drugs by Application in 2024

Table 81. Beijing Yuekang Revenue Proportion of Anti-Peptic Ulcer Drugs by Geographic Area in 2024

Table 82. Beijing Yuekang Recent Developments

Table 83. Guangdong Dahua Corporation Information

Table 84. Guangdong Dahua Description and Business Overview

Table 85. Guangdong Dahua Anti-Peptic Ulcer Drugs Product

Table 86. Guangdong Dahua Anti-Peptic Ulcer Drugs Revenue (US$ Million) and Gross Margin (2020-2025)

Table 87. Guangdong Dahua Revenue Proportion of Anti-Peptic Ulcer Drugs by Product in 2024

Table 88. Guangdong Dahua Revenue Proportion of Anti-Peptic Ulcer Drugs by Application in 2024

Table 89. Guangdong Dahua Revenue Proportion of Anti-Peptic Ulcer Drugs by Geographic Area in 2024

Table 90. Guangdong Dahua Recent Developments

Table 91. Xian Janssen Corporation Information

Table 92. Xian Janssen Description and Business Overview

Table 93. Xian Janssen Anti-Peptic Ulcer Drugs Product

Table 94. Xian Janssen Anti-Peptic Ulcer Drugs Revenue (US$ Million) and Gross Margin (2020-2025)

Table 95. Xian Janssen Revenue Proportion of Anti-Peptic Ulcer Drugs by Product in 2024

Table 96. Xian Janssen Revenue Proportion of Anti-Peptic Ulcer Drugs by Application in 2024

Table 97. Xian Janssen Revenue Proportion of Anti-Peptic Ulcer Drugs by Geographic Area in 2024

Table 98. Xian Janssen Recent Developments

Table 99. North America Anti-Peptic Ulcer Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 100. North America Anti-Peptic Ulcer Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 101. North America Anti-Peptic Ulcer Drugs Revenue by Type (2020-2025) & (US$ Million)

Table 102. North America Anti-Peptic Ulcer Drugs Revenue by Application (2020-2025) & (US$ Million)

Table 103. Asia-Pacific Anti-Peptic Ulcer Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 104. Asia-Pacific Anti-Peptic Ulcer Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 105. Asia-Pacific Anti-Peptic Ulcer Drugs Revenue by Type (2020-2025) & (US$ Million)

Table 106. Asia-Pacific Anti-Peptic Ulcer Drugs Revenue by Application (2020-2025) & (US$ Million)

Table 107. Europe Anti-Peptic Ulcer Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 108. Europe Anti-Peptic Ulcer Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 109. Europe Anti-Peptic Ulcer Drugs Revenue by Type (2020-2025) & (US$ Million)

Table 110. Europe Anti-Peptic Ulcer Drugs Revenue by Application (2020-2025) & (US$ Million)

Table 111. Latin America Anti-Peptic Ulcer Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 112. Latin America Anti-Peptic Ulcer Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 113. Latin America Anti-Peptic Ulcer Drugs Revenue by Type (2020-2025) & (US$ Million)

Table 114. Latin America Anti-Peptic Ulcer Drugs Revenue by Application (2020-2025) & (US$ Million)

Table 115. Middle East and Africa Anti-Peptic Ulcer Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 116. Middle East and Africa Anti-Peptic Ulcer Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 117. Middle East and Africa Anti-Peptic Ulcer Drugs Revenue by Type (2020-2025) & (US$ Million)

Table 118. Middle East and Africa Anti-Peptic Ulcer Drugs Revenue by Application (2020-2025) & (US$ Million)

Table 119. Anti-Peptic Ulcer Drugs Key Raw Materials, Industry Status and Trend

Table 120. Anti-Peptic Ulcer Drugs Key Raw Materials and Upstream Suppliers

Table 121. Anti-Peptic Ulcer Drugs Clients Status and Trend

Table 122. Anti-Peptic Ulcer Drugs Typical Clients

Table 123. Anti-Peptic Ulcer Drugs Distributors

Table 124. Anti-Peptic Ulcer Drugs Market Trends

Table 125. Anti-Peptic Ulcer Drugs Market Drivers

Table 126. Anti-Peptic Ulcer Drugs Market Challenges

Table 127. Anti-Peptic Ulcer Drugs Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Anti-Peptic Ulcer Drugs Product Picture

Figure 2. Global Anti-Peptic Ulcer Drugs Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Anti-Peptic Ulcer Drugs Revenue Market Share by Type in 2024 & 2031

Figure 4. Proton Pump Inhibitors (PPIs) Product Picture

Figure 5. Potassium-Competitive Acid Blockers (P-CAB) Product Picture

Figure 6. Antacids Product Picture

Figure 7. H2 Antagonists Product Picture

Figure 8. Ulcer Protective Drugs Product Picture

Figure 9. Global Anti-Peptic Ulcer Drugs Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 10. Global Anti-Peptic Ulcer Drugs Revenue Market Share by Application in 2024 & 2031

Figure 11. Gastritis

Figure 12. Gastric Ulcers

Figure 13. Duodenal Ulcers

Figure 14. Gastroesophageal Reflux Disease (GERD)

Figure 15. Anti-Peptic Ulcer Drugs Report Years Considered

Figure 16. Global Anti-Peptic Ulcer Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Anti-Peptic Ulcer Drugs Market Size (2020-2031) & (US$ Million)

Figure 18. Global Anti-Peptic Ulcer Drugs Market Size Market Share by Region: 2024 Versus 2031

Figure 19. Global Anti-Peptic Ulcer Drugs Revenue Market Share by Region (2020-2031)

Figure 20. Global Anti-Peptic Ulcer Drugs Revenue Market Share Forecast by Type (2020-2031)

Figure 21. Global Anti-Peptic Ulcer Drugs Revenue Market Share Forecast by Application (2020-2031)

Figure 22. Proton Pump Inhibitors (PPIs) of Anti-Peptic Ulcer Drugs Revenue Market Share by Application, 2024 VS 2031

Figure 23. Potassium-Competitive Acid Blockers (P-CAB) of Anti-Peptic Ulcer Drugs Revenue Market Share by Application, 2024 VS 2031

Figure 24. Antacids of Anti-Peptic Ulcer Drugs Revenue Market Share by Application, 2024 VS 2031

Figure 25. H2 Antagonists of Anti-Peptic Ulcer Drugs Revenue Market Share by Application, 2024 VS 2031

Figure 26. Ulcer Protective Drugs of Anti-Peptic Ulcer Drugs Revenue Market Share by Application, 2024 VS 2031

Figure 27. Anti-Peptic Ulcer Drugs Revenue Share by Company (2024)

Figure 28. Anti-Peptic Ulcer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 29. Proton Pump Inhibitors (PPIs) Revenue Proportion by Company in 2024

Figure 30. Potassium-Competitive Acid Blockers (P-CAB) Revenue Proportion by Company in 2024

Figure 31. Antacids Revenue Proportion by Company in 2024

Figure 32. H2 Antagonists Revenue Proportion by Company in 2024

Figure 33. Ulcer Protective Drugs Revenue Proportion by Company in 2024

Figure 34. North America Anti-Peptic Ulcer Drugs Revenue 2020-2031 (US$ Million)

Figure 35. North America Anti-Peptic Ulcer Drugs Revenue Market Share by Type (2020-2025)

Figure 36. North America Anti-Peptic Ulcer Drugs Revenue Market Share by Application (2020-2025)

Figure 37. Asia-Pacific Anti-Peptic Ulcer Drugs Revenue 2020-2031 (US$ Million)

Figure 38. Asia-Pacific Anti-Peptic Ulcer Drugs Revenue Market Share by Region (2020-2031)

Figure 39. Asia-Pacific Anti-Peptic Ulcer Drugs Revenue Market Share by Type (2020-2025)

Figure 40. Asia-Pacific Anti-Peptic Ulcer Drugs Revenue Market Share by Application (2020-2025)

Figure 41. Europe Anti-Peptic Ulcer Drugs Revenue Growth Rate 2020-2031 (US$ Million)

Figure 42. Europe Anti-Peptic Ulcer Drugs Revenue Market Share by Country (2020-2031)

Figure 43. Europe Anti-Peptic Ulcer Drugs Revenue Market Share by Type (2020-2025)

Figure 44. Europe Anti-Peptic Ulcer Drugs Revenue Market Share by Application (2020-2025)

Figure 45. Latin America Anti-Peptic Ulcer Drugs Revenue Growth Rate 2020-2031 (US$ Million)

Figure 46. Latin America Anti-Peptic Ulcer Drugs Revenue Market Share by Country (2020-2031)

Figure 47. Latin America Anti-Peptic Ulcer Drugs Revenue Market Share by Type (2020-2025)

Figure 48. Latin America Anti-Peptic Ulcer Drugs Revenue Market Share by Application (2020-2025)

Figure 49. Middle East and Africa Anti-Peptic Ulcer Drugs Revenue Growth Rate 2020-2031 (US$ Million)

Figure 50. Middle East and Africa Anti-Peptic Ulcer Drugs Revenue Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Anti-Peptic Ulcer Drugs Revenue Market Share by Type (2020-2025)

Figure 52. Middle East and Africa Anti-Peptic Ulcer Drugs Revenue Market Share by Application (2020-2025)

Figure 53. Anti-Peptic Ulcer Drugs Supply Chain (Upstream and Downstream Market)

Figure 54. Global Production Market Share of Anti-Peptic Ulcer Drugs Raw Materials by Region in 2024

Figure 55. Anti-Peptic Ulcer Drugs Distribution Channels

Figure 56. Global Anti-Peptic Ulcer Drugs Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 57. Global Anti-Peptic Ulcer Drugs Percentage 2020-2031: Online Sales VS Offline Sales

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Proton Pump Inhibitors Market

Global Peptic Ulcer Disease Medication Market Research Report 2025

Global Peptic Ulcer Medication Market Research Report 2024

Global Antiulcerant Drugs Market Insights Forecast to 2030

Global Peptic Ulcer Treatment Drugs Market Research Report 2024

Global Gastric Antisecretory Drug Market Insights Forecast to 2030

Global Stomach Medicine Market Research Report 2024

Global Stomach Acid Suppressing Drug Market Research Report 2024

Peptic Ulcer Relief Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Stomach Peptic Ulcer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gastric Mucosal Protective Drugs Market Research Report 2024

Global Gastric Cancer Drugs Market Research Report 2024

Global Prescription Proton Pump Inhibitor Market Research Report 2024

Global Oral Ulcer Drug Market Research Report 2024

Global Antiulcer Agents and Acid Suppressants Market Research Report 2024

Global Oral Proton Pump Inhibitors PPIs Market Research Report 2024

Global Proton Pump Inhibitors PPIs Market Research Report 2024

Gastric Motility Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Stomach Cancer Drugs Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions